| February 2019 |
|
|
Committee Announces Rescheduling of Michael Cohen’s Public Testimony
|
|
|
Multiple Whistleblowers Raise Grave Concerns with White House Efforts to Transfer Sensitive U.S. Nuclear Technology to Saudi Arabia
|
|
|
House, Senate Democrats Send Secretary DeVos Second Request for Information Regarding Attempt to Undermine Independence of Education Department Watchdog
|
|
|
President’s Lawyers Provided False Information to Government Officials on Stormy Daniels Payment, New Documents Show
|
|
|
House Committee Leaders Request Extension of Public Comment Periods Affected by the Government Shutdown
|
|
|
Democrats Object to “Unconventional and Nontransparent” Review Process for Rule to Undermine Family Planning
|
|
|
Cummings, Grijalva, and Speier Express Concern with Forest Service’s Failure to Address Sexual Harassment
|
|
|
Trump Appointee Has Avoided Investigation And Should Face Discipline, New DHS Memo Says
|
|
|
Cummings and Connolly Introduce Legislation to Protect the Merit Systems Protection Board
|
|
|
Wexton, Cummings, and Connolly Investigate Delayed Back Pay and Payroll Problems for Furloughed and Excepted Federal Employees
|
|
|
House Passes Bipartisan Legislation to Make Presidential Library Funding Transparent
|
|
|
New Documents Show Acting Attorney General Failed to Pay Back Funds After Company Charged with Bilking Consumers
|
|
|
Cummings, Collins, Booker, Johnson Introduce Bipartisan, Bicameral Legislation to “Ban the Box”
|
|
|
Cummings Seeks Documents From Immigration Ombudsman After Receiving Troubling Allegations
|
|
|
Warren, Carper, Cummings Introduce Transition Team Ethics Improvement Act
|
|
|
Chairman Cummings’ Opening Statement at H.R. 1 Hearing
|
|
|
Committee Examined Ethics Proposals in H.R. 1
|
|
|
Senators Peters & Feinstein and Rep. Cummings Announce GAO Report Showing Trump Spent $13.6 Million in Tax Dollars on Mar-a-Lago Travel
|
|
|
Democrats Hold Key Hearings on H.R. 1—The “For the People” Act
|
|
|
Cummings Announces Hearing With ONDCP Director on New White House Drug Strategy
|